CD4 and myeloid sarcoma: Several studies had clarified the immunological mechanisms at the basis of these long-term effects, mechanisms involving mainly a particular immunoreconstitution of CD4+ T lymphocyte subsets, strengthening their role in MS disease pathology and therapy and a reshuffle of the immune system from inflammation toward suppression.